HCW Biologics Secures U.S. Patent Allowance for HCW9302 in Alopecia Areata

HCW Biologics Inc. (the “Company” or “HCW Biologics”), a U.S.-based clinical-stage biopharmaceutical company focused on developin...

September 04, 2026 | Friday | News
Inventiva Completes Final Patient Visits in Phase 3 NATiV3 Trial of Lanifibranor for MASH

Inventiva(“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of an oral small m...

September 04, 2026 | Friday | News
HUTCHMED and GSK Enter Exclusive Global License Agreement for Novel KRAS-Targeted Cancer Therapy

HUTCHMED (China) Limited (“HUTCHMED”) announces that its subsidiary, HUTCHMED Limited, has entered into an exclusive development and license ...

September 04, 2026 | Friday | News
ONWARD Medical Implants First ARC-IM System in EIGER Study to Advance Mobility Recovery After Spinal Cord Injury

ONWARD Medical N.V., the neurotechnology company pioneering spinal cord stimulation therapies to restore movement, function, and independence, announces ...

September 04, 2026 | Friday | News
Ono Pharma Partners With Aitia to Discover New Neurological Disease Targets Using Causal AI

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”) announced that it has entered into a drug ...

September 03, 2026 | Thursday | News
Andelyn Biosciences to Scale Up Genprex’s AAV-Based Diabetes Gene Therapy Program

Andelyn Biosciences, a leading contract development and manufacturing organization, announced that Genprex, Inc. has selected Andelyn to support scale-up...

September 03, 2026 | Thursday | News
SciSparc Advances SCI-210 Clinical Trial for Autism Symptoms as Enrollment Reaches 26 Children

SciSparc Ltd. (“Company” or “SciSparc”), announced that NeuroThera Labs Inc.  ("NeuroThera"), a clinical-stage pharmaceuti...

September 02, 2026 | Wednesday | News
NexLife Expands Compounded GLP-1 Program With Four Protocols Under Flat-Rate Pricing Model

NexLife, a LegitScript-certified, physician-led telehealth platform, announced that its compounded GLP-1 program now spans four protocols under a single ...

September 02, 2026 | Wednesday | News
Arrowhead Pharmaceuticals’ Plozasiran Cuts Triglycerides by Up to 81% in Phase 3 SHASTA Trials

- Plozasiran reduced triglycerides (TG) by 79% and 81% versus placebo in SHASTA-3 and SHASTA-4 across the broad sHTG population - - More than 90% of p...

September 01, 2026 | Tuesday | News
Leios Therapeutics Grants CMS Exclusive China Rights to 10XB-101 for Focal Fat Reduction

10XB-101 is a Novel Potential Best-in-Class Injectable Drug Being Developed for Focal Fat Reduction and Body Contouring  Second Major Regional Lice...

September 01, 2026 | Tuesday | News
Teva Bids to Acquire BioXcel’s Novel At-Home Neuroscience Treatment for Agitation

Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. announced it has made a bid to acquire an innovative neurosc...

August 31, 2026 | Monday | News
Revolution Medicines Wins FDA Approval for RASONQUE in Metastatic Pancreatic Cancer

Revolution Medicines, Inc., a global commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for patie...

August 28, 2026 | Friday | News
Immuneering Advances Atebimetinib Phase 3 Trial in First-Line Metastatic Pancreatic Cancer

Immuneering Corporation, a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, shared comments followi...

August 28, 2026 | Friday | News
Thermo Fisher Scientific Launches Orbitrap Isora Mass Spectrometers for Molecular-Level Isotope Analysis

Thermo Fisher Scientific, the world leader in serving science, introduced the Thermo Scientific Orbitrap Isora Mass Spectrometer and Orbitrap Isora Pro M...

August 27, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close